Serum levels of ochratoxin A in healthy subjects and in nephropathic patients in Tunisia

Annales de Biologie Clinique

Volumn 66, Issue 6, 2008, Pages 631-636

  Hmaissia Khlifa, K ^a   Ghali, R ^b   Mezigh, C ^a   Aouni, Z ^a   Ghorbel, H ^b   Harrzallah, K ^a   Machgoul, S ^a   Hedhili, A ^b  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b Research Unit   (Tunisia)

Author keywords

HPLC; Nephropathy; Ochratoxin A; Tunisia

Indexed keywords

OCHRATOXIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; TUNISIA;

ADULT; AGED; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; FEMALE; FLUORESCENCE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OCHRATOXINS; TUNISIA;

ASPERGILLUS; FUNGI;

EID: 58149398805     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2008.0278     Document Type: Article

References (24)

1. Pena A, Seifrtova AC, Lino AI, et al. Estimation of ochratoxin A in portuguese population: New data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem Toxicol 2006; 44: 1449-54.
2. Ghali R, Hmaissia-khlifa K, Ghorbel H, et al. Incidence of aflatoxins, ochratoxin A and zearalenone in tunisian foods. Food Control 2008; 19: 921-4 (Article in press).
3. Arbillaga L, Azqueta A, van Delft JHM, et al. In vitro gene expression data supporting a DNA non reactive genotoxic mechanism for ochratoxin A. Toxicol Applied Pharmacol 2007; 220: 216-24.
4. Mayura K, Parker R, Berndt WO, et al. Ochratoxin A induced teratogenesis in rats : partial protection by phenylalanine. Appl Env Micro 1984; 48: 1186-8.
5. Creppy EE, Stormer FC, Röschenthler R, et al. Effects of two metabolites of ochratoxin A (4R)-4- hydroxyochratoxin A and ochratoxin A on immune response in mice. Infect Immun 1983; 39: 1015-8.
6. Pfohl-Leskowicz A, Grosse Y, Kane A, et al. Differentiel DNA-adducts formation and disapperance in three mice tissus after treatement by the mycotoxin ochratoxin A. Mutat Res 1993; 289: 265-73.
7. Obrecht-Pflumio S, Chassat T, Dirheimer G, et al. Genotoxicity of ochratoxin A by Salmonelle mutagenicity test after bioactivation by mouse kidney microsomes. Gen Tox Environ Mut 1999; 446: 95-102.
8. Petkova-Bocharova T, Castegnaro M. Ochratoxin A in human blood in relation to balkan endemic nephropathy and urinary tract tumours in Bulgaria. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IV, Bartsch H, eds. Mycotoxin, endemic nephropathy and urinary tract tumours. Lyon: International Agency for research on Cancer, 1991: 135-7 (IARC Sci. Publ. no. 115).
9. Pfohl-Leskowicz A, Petkova-Bocharova T, Chernozemsky IN, et al. Balkan endemic nephropathy and associated urinary tract tumors : a review on aetiological causes and the potentiel role of mycotoxins. Food Addit Contam 2002; 19: 282-302.
10. Gekle M, Sauvant C, Schwerdt G. Ochratoxin A at nanomolar concentrations : a signal modular in renal cells. Mol Nutr Food Res 2005; 49: 118-30.
11. Long DT, Voice TC. Role of exposure analysis in solving the mystery of Balkan endemic nephropathy. Croat Med J 2007; 48: 300-11.
12. Maaroufi K, Achour A, Betbeder AM, et al. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A : correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol 1995: 552-8.
13. Hassen W, Abid S, Achour A, et al. Ochratoxin A and human nephropathy in Tunisia : a ten year survey. Ann Toxicol Anal 2003; 15: 21-9.
14. Abid S, Hassen W, Achour A, et al. Ochratoxin A and human chronic nephropathy in Tunisia : is the situation endemic ? Hum Exp Tox 2003; 22: 77-84.
15. Eko-Ebongue S, Antalick JP, Bonini M, et al. Détermination des teneurs en ochratoxine A, vitamine E et vitamine A dans les sérums humains de France et de Tunisie : recherche d'une corrélation. Ann Falsification Exp Chimique 1994; 929: 213-24.
16. Ózcelik N, Kosar A, Soysal D. Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett 2001; 121: 9-13.
17. Wafa EW, Yahya RS, Sobh MA, et al. Human ochratoxicosis and nephropathy in Egypt : a preliminary study. Hum Exp Toxicol 1998; 17: 124-9.
18. Khalef A, Zidane C, Charef A, et al. Ochratoxicoses humaines en Algérie. In: Creppy E, Castegnaro M, Dirheimer G, eds. Human ochratoxicosis and its pathologies. Inserm 231. Paris: John Libbey Eurotext, 1993: 123-7.
19. Radic B, Fuchs R, Peraica M, Lucic A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett (Amst) 1997; 92: 105-9.
20. Palli D, Miraglia M, Saieva C, et al. Serum levels of ochratoxin A in healthy adults in Tuscany : correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarkers Prev 1999; 8: 265-9.
21. Grosso F, Said S, Mabrouk I, et al. New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol 2003; 41: 1133-40.
22. Bacha H, Maaroufi K, Achour A, et al. Ochratoxines et ochratoxicoses humaines en Tunisie. In: Creppy E, Castegnaro M, Dirheimer G, eds. Human ochratoxicosis and its pathologies. Inserm 231. Paris: John Libbey Eurotext, 1993: 111-21.
23. Bacha H, Maaroufi K, Ghédira-Chékir L, et al. Mycotoxins and mycotoxicosis in Tunisia : what do we know and what do we need to know? J Toxicol Tox Rev 1998; 18: 254-62.
24. Maaroufi K, Achour A, Hamammi M, et al. Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 1995; 14: 609-15.